BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Leukemia
,
Prostate
,
Early pregnancy factor
,
Ciprofibrate
,
rs6983267
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gzmb protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Natural killer cell miRNA expression in response to activation by IL-15
CD57-negative and positive cytotoxic T-cells from Waldenstrom's Macroglobulinaemia patients
Explore Curated Studies Results
Literature
Most Relevant Literature
The Use of the Antigenic Protein HPV6 L1 to Induce the Synthesis of Interferon, CD4 and CD8 T Lympho…
Granzyme B in epithelial barrier dysfunction and related skin diseases.
Structural insights into the catalytic mechanism of granzyme B upon substrate and inhibitor binding.
Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mut…
C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor micro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative…
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in…
Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN
Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ